Insulin resistance, which both causes and is caused by visceral fat, creates a metabolic trap where the body preferentially stores energy as belly fat while struggling to release it
Fast absorption, no injections needed
Monitor your bodys response closely
Tirzepatide GLP-1 is a dual-action metabolic therapy that supports weight control by improving insulin sensitivity, reducing appetite, and enhancing satiety
For musculoskeletal, tendon, ligament, or systemic targets, injection is the better-supported route because all relevant animal healing studies used injected BPC-157, and systemic absorption from capsules in humans is unverified
10.1111/j.1365-2036.2008.03784.x 6